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ABSTRACT 
 
Background: This study examined factors associated with the use of prescribed 
medication at work. 
Methods: Questionnaire survey of employees with diagnosed chronic illnesses from 
four UK organisations.  Data was collected on type of chronic illness, health status, 
health beliefs, work limitations, occupational health support, GP and line manager 
support. Data was analysed using  Univariate logistic regression. 
Results:  1474 employees with chronic illness participated. Medication use at work 
(yes v no) was predicted by age, pain, diagnosis of heart disease, medication use at 
home, benefit of prescribed medication to health, ease of using medication at work, 
practical support from families and practical and emotional support from GP and line 
manager.  In a multivariate logistic regression model, medication use at work was 
predicted by medication use at home and ease of using medication at work only.   
Conclusions: The ease of taking medication at work was found to be a key predictor 
of medication use at work, suggesting occupational health may play a vital role in 
findings ways to support employees in their usage of medication. This may be for 
example by providing help and guidance in storing medication at work and 
encouraging employees to disclose medication use to employers and managers where 
necessary. Occupational health services can help create a workplace culture that 
places a high value on health, educating staff on the value of looking after their health 
and the benefits of following advice. 
 
Abstract word count: 225 
Key words: chronic illness, medication use, support, workplace intervention
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INTRODUCTION 
 
As the incidence of chronic illnesses increases, the number of prescriptions for 
medication has increased sharply (1-5).  Evidence suggests that use of medication and 
adherence relies heavily on patients and the health services (6).  Although certain 
patient characteristics are associated with medication use (7 8), it is now understood 
that social and psychological variables are among the most significant factors that 
influence medication use, such as physician-patient communication, illness 
perceptions, health beliefs and support from GPs, families and significant others (9 
10).  However, for many patients, the majority of their day-to-day use and 
management of medication takes place at work (11).  Most research in this area has 
not considered the effect of work-related factors on medication use.  
 
It is possible that medication use at work is influenced by work-related social and 
psychological variables, such as work limitations, line manager support and the 
opportunity to take prescribed medication at work.  Some evidence suggests that for 
workers managing anxiety and depression, the work environment plays a pivotal role 
in their medication use and adherence (1-5).  For example, Haslam et al (1-3) found 
that side effects of psychotropic medication for those with anxiety and depression 
interfered with work performance and non-compliance was reported to be widespread.  
Lack of information and workplace support was also associated with non-compliance.  
Haslam et al (2) argued that lack of compliance can present a serious health and safety 
risk in the workplace in terms of not only increasing the risk of further health 
deterioration, but also the’ knock-on’ effects this may have on sickness absence, 
presenteeism and work productivity.  Further research is needed to explore whether 
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these factors are isolated to medication use for anxiety and depression, or extend to 
other illnesses.  Specifically, work-related factors associated with prescribed 
medication use at work among employees with chronic illness are of importance 
given the increasing prevalence and enduring nature of chronic illnesses (5). This 
study aimed to examine the role of workplace support, GP support, health perceptions 
of medication use at work and the influence of work performance on medication use 
at work among employees with chronic illness.  
 
METHODS 
 
Participants were employees from four organisations across three sectors: local 
government, transport and manufacturing (two companies).  To ensure anonymity, 
employees were randomly sent a questionnaire through their occupational health 
departments. We approached all employees in the two manufacturing companies 
(5,000 employees), and randomly selected 1:3 employees in the local government 
(employing 21,000 employees) and 1:2 employees in the transport organisation 
(employing 12,000 employees).  Completed questionnaires were returned directly to 
the research team.  To monitor overall response rates, the questionnaire asked all 
employees, independent of their health status for demographic and job-related details.  
Employees managing a chronic illness were asked additional questions about their 
health and work.  
 
The questionnaire asked participants to report any medically diagnosed chronic illness 
currently experienced, and to indicate which primary condition (if more than one was 
listed) most affected their work.  This measure is consistent with other self-report 
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measures of chronic illness (11,15,16).  A total of 17 different groups of chronic 
illnesses were identified from the sample.  Nine illnesses were clearly identified: 
asthma, irritable bowel syndrome, diabetes, migraine, thyroid disease, inflammatory 
bowel disease, multiple sclerosis, chronic fatigue syndrome, epilepsy, HIV and 
hepatitis (B and C).  For depression and anxiety, participants were grouped if they 
reported either depression, anxiety or a combination of both.  The International 
Classification of Diseases (17) was used to classify the following illnesses: 
Musculoskeletal pain consisted of participants reporting pain anywhere along the 
musculoskeletal system (e.g. back, shoulders, neck, arms, elbows, wrist, and lower 
limbs).  Heart disease included myocardial infarction, angina, heart failure, stroke and 
hypertension.  For cancer, participants were included if they reported any type of 
cancer.  Eye problems included glaucoma, sensory neuropathy and blepharitis.  
Reproductive and gynaecological problems included endometriosis and menstruation 
problems.  For arthritis and rheumatism, participants were included if they reported 
any form of arthritis, spondylitis and fibromyalgia. A further group was classified as 
‘Other’, which represented smaller numbers of reported other chronic illness.  
Employees were also asked how long they had their illness (years). 
 
Prescribed medication use at home and at work was assessed by a modified version of 
the illness symptoms Self-Management Behaviours Scale (19; 20).  Participants were 
asked to rate how closely they were following their doctor’s advice in taking 
prescribed medication related to their chronic illness at home and at work (two items).  
Responses were measured on a 10 point Likert scale (“Not closely” to “Very closely”) 
and had an internal consistency of  = .84.  Based on the same scale (19), participants 
were also asked to rate how beneficial they felt it was to their health to take 
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medication at work (one item, measured on a 10-point-Likert scale from “Not 
beneficial at all” to “Very beneficial”).  They were also asked if it was easy for them 
to take medication at work (yes, no). 
 
Health status was assessed by a modified version of the pain severity scale (two items, 
 = .66); fatigue (one item) and health distress (4 items,  = .89). All items were 
taken from the MOS survey of health status (18), and measured on a five-point Likert 
scale.  A mean score was calculated for the health distress scale.  Severity of 
symptoms (one item) was also measured (mild to severe). 
 
The Work Limitations Questionnaire (21) was used to assess the degree to which 
employees’ symptoms of chronic illness interfered with specific aspects of job 
performance.  The questionnaire asks employees to rate on a five point Likert scale, 
their level of difficulty (or ability) to perform 25 specific job demands corresponding 
to four scales: time management (five items,  = .88), physical demands (six items,  
= .90); mental interpersonal (nine items,  = .92) and output demands (five items,  = 
.94). A total scale score was calculated to indicate overall work limitation, where a 
higher score indicated more work limitation (21). 
 
Support consisted of two forms of workplace support: practical (giving information, 
help and advice) and emotional support (sympathy and understanding).  These were 
measured with four items each, representing support received from line manager, 
occupational health, family and GP in the management of chronic illness.  Items were 
measured on a five-point Likert scale (“No support” to “A great deal of support”) and 
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had an internal consistency of = .83 (line manager) = .81 (occupational health), = 
.88 (family) and = .87 (GP).  
 
Data were collected on age (years), sex, tenure (length of employment, years), 
employment status (part/full-time) and education (none, GCSE, AS level A level or 
equivalent, degree, higher degree). 
 
Correlations were computed for all variables.  Those which significantly correlated 
with the medication use at work were subjected to logistic regression analysis to 
examine their association with medication use at work (as the distribution of 
responses showed high relative frequencies of minimum and maximum scores 
indicating that participants were either likely to take medication or not, scores 1-5 
were dichotomised into ‘no’ and scores 6-10 were dichotomised into ‘yes’).  For 
analyses, age was classified as 18-30, 31-43, 44-56 and 57-69.  A score of 1 was 
given if a chronic illness was present and a score of 0 if any other illness was present.  
Those proven to be significant predictors at p<0.001 (Bonferroni correction) were 
entered into a multiple logistic regression analysis to identify the strongest predictors.  
 
A review of each organisation’s policy in medication use showed the transport 
organisation required employees to disclose medication use for health and safety 
reasons. Therefore, to control for organisational differences in medication policies, 
each organisation was entered as a covariate in step 1 of the analyses using dummy 
coding (1 = organisation with medication policy, 0 = all other organisations). 
Ethical approval was granted by The Institute of Work, Health & Organisations, 
University of Nottingham,local ethics committee.. 
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RESULTS 
1474 participants reported at least one chronic illness giving a response rate of 28% 
for completed returned questionnaires. The remaining sample did not report a chronic 
illness and were excluded from further analysis.  
Table 1 reports demographic and illness-related variables.  This was compared 
with data obtained from each organisation’s human resources department (non-
responders).  Participants with chronic illnesses did not significantly differ from their 
respective colleagues in terms of gender and occupational status (all p>.05). However, 
those reporting heart disease and arthritis and rheumatism were significantly older 
than non-responders (p<.05).  Across organisations, musculoskeletal pain was the 
most reported condition.  For administration and manufacturing A organisations, 
arthritis and rheumatism was the second most prevalent condition.  For transport and 
manufacturing B, asthma was the second most reported condition. Across the sample, 
85% (n=1256) reported using prescribed medication at work related to their primary 
chronic illness affecting work.  Table 2 reports the means and standard deviations for 
medication use at home and at work and were compared between the chronic illness 
groups using multivariate analysis of co-variance (MANCOVA).  Illness group was 
entered as the independent variable.  Age, gender, organisation, education, severity of 
illness and length of time managing an illness were entered as covariates.  A 
Bonferroni corrected alpha level of p≤.0.001 was accepted as statistically significant.  
MANCOVA revealed a significant main effect between groups [F(1, 16) = 4.45; 
p<0.001].  Tukeys post hoc analyses showed those with musculoskeletal pain were 
less likely to use medication both at work and at home than all other groups 
(p<0.001).  No other significant group differences were found. There was a significant 
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main effect within-group [F(1, 1112) = 163.14; p<0.001], indicating that medication 
behaviour significantly differed between home and work.  T-tests revealed those with 
arthritis, asthma, musculoskeletal pain, depression and anxiety, diabetes, migraine and 
irritable bowel syndrome were more likely to take medication at home than at work 
(all ps<0.001).  
 
Table 3 shows the correlations between the outcome variable ‘medication use 
at work’ and all other variables. The correlations range from r = 0.01 to r =0.60; 
indicating no highly significant problems with multicollinearity.. The adjusted odds 
ratios of predictors for medication use at work are presented in Table 4.  For 
demographic and illness-related variables, only age and pain were related to 
medication use at work (p<0.001).  Participants with diagnosed heart disease were 
more likely to use medication at work and those with diagnosed musculoskeletal pain 
and depression and anxiety were less likely to use medication at work compared with 
other chronic illnesses.  The use of medication at home increased the likelihood of 
medication use at work and the easy use of medication at work was also predictive of 
medication use at work.  The perceived benefit of prescribed medication to health was 
also associated with medication use at work.  In terms of support, instrumental 
support from line manager, GP and from family were associated with medication use 
at work.  Support from occupational health was not associated with medication use at 
work.  Work-limitation was also not associated with medication use at work. The 
variables associated with medication use at work were then entered into a multiple 
logistic regression model. A Bonferroni corrected alpha level of p≤0.001 was 
accepted as statistically significant. 
 
Factors associated with medication use at work 
 11 
 
Table I:  Distribution of chronic illness and demographic details across participants (n= 
1474) 
 
  
n 
 
(%) 
 
M 
 
SD 
 
Age (years) 
Tenure (years) 
Length of time managing a chronic illness 
(years) 
Gender 
  Male 
  Female 
Education  
  None 
  GCSE or equivalent 
  AS level or equivalent 
  A level of equivalent 
  Degree 
  Higher degree 
Employment status 
  Full time 
  Part time 
Chronic illness 
  Musculoskeletal pain 
  Arthritis & rheumatism 
  Asthma 
  Depression & anxiety 
  Irritable bowel syndrome 
  Heart disease 
  Diabetes 
  Migraine 
  Thyroid disease 
  Inflammatory bowel disease 
  Cancer 
  Reproductive & gynaecological 
  Multiple Sclerosis 
  Eye problems 
  Chronic fatigue syndrome 
  HIV & hepatitis 
  Epilepsy 
  Other+ 
Severity 
  Mild  
  Moderate  
  Severe 
Presence of pain 
Severity of pain 
  Mild 
  Moderate 
  Severe 
Fatigue  
Illness distress score 
Medication use at home 
Medication use at work 
 
 
 
 
 
 
 
640 
834 
 
252 
439 
38 
246 
354 
103 
 
1055 
403 
 
324 
192 
174 
152 
115 
96 
91 
80 
51 
43 
25 
17 
17 
16 
16 
16 
14 
35 
 
708 
482 
245 
944 
 
229 
427 
349 
1094 
 
1347 
1256 
 
 
 
 
 
 
 
(43) 
(57) 
 
(18) 
(31) 
(3) 
(17) 
(25) 
(7) 
 
(72) 
(28) 
 
(22) 
(13) 
(12) 
(10) 
(8) 
(7) 
(6) 
(5) 
(4) 
(3) 
(2) 
(1) 
(1) 
(1) 
(1) 
(1) 
(1) 
(2) 
 
(49) 
(34) 
(17) 
(64) 
 
(23) 
(43) 
(35) 
(74) 
 
(93) 
(85) 
 
46.2 
13.4 
11.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.9 
 
9.1 
9.9 
10.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3 
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Table 5 shows the multivariate model of significant predictors (2 =18.24, df=2; 
p<0.01).  The final model (sensitivity 63% and specificity 95%) accurately classified 
89% of the cases.  In the final model, only medication use at home and ease of taking 
medication at work predicted medication use at work.   
 
 
Table II: Comparison of medication use across participants 
 
 
 Medication use at work 
 
Medication use at home Paired t-test 
Mean (SD) p value Mean SD p value p value 
 
Musculoskeletal pain 
Arthritis & rheumatism 
Asthma 
Depression & anxiety 
Irritable bowel syndrome 
Heart disease 
Diabetes 
Migraine 
Thyroid disease 
Inflammatory bowel disease 
Cancer 
Reproductive & gynaecological 
Multiple Sclerosis 
Eye problems 
Chronic fatigue syndrome 
HIV & hepatitis 
Epilepsy 
 
6.73 
7.87 
8.14 
7.66 
7.64 
9.00 
8.11 
7.90 
9.06 
8.56 
8.41 
8.80 
7.67 
8.73 
9.43 
8.46 
9.78 
 
(3.12) 
(2.73) 
(2.46) 
(3.01) 
(2.73) 
(2.03) 
(2.56) 
(2.66) 
(1.54) 
(2.40) 
(2.80) 
(1.54) 
(3.06) 
(1.72) 
(1.78) 
(1.61) 
(1.55) 
 
<0.001* 
 
7.73 
8.65 
8.70 
8.71 
8.59 
9.58 
8.85 
8.71 
9.47 
8.78 
9.52 
9.15 
8.00 
9.23 
9.67 
9.29 
9.82 
 
(2.79) 
(2.18) 
(2.04) 
(2.30) 
(2.02) 
(1.40) 
(1.87) 
(2.14) 
(1.51) 
(2.09) 
(1.93) 
(1.40) 
(2.79) 
(1.36) 
(1.70) 
(1.31) 
(1.40) 
 
<0.001* 
 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
  0.02 
<0.001 
<0.001 
  0.05 
  0.11 
  0.14 
  0.17 
  0.58 
  0.42 
  0.35 
  0.19 
  0.35 
 
*Between group comparisons: musculoskeletal pain significantly differed from all other groups 
 
 
Table III: Correlations among the key variables 
 
 
Variables  M SD 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1. Gendera - - -                  
2. Age   -.04 -                 
3. Tenure   -0.19** 0.46** -                
4. Education level   0.00 -.15* -0.18* -               
5. working hours   0.45** 0.11* -0.09 -0.16* -              
6. Medication use at workc   0.05 0.11* 0.03 0.05 0.05 -             
7. Ease of medication use at workd   0.04 -0.05 -0.03 0.08 0.06 0.28** -            
8. Medication beneficial to health   0.08 0.13* -0.01 0.01 0.04 0.38** 0.12* -           
9. Medication use at home   0.06 0.16* 0.07 0.04 0.06 0.60** 0.12* 0.48** -          
10. Illness severity   0.05 0.04 0.04 -0.21** 0.03 -0.05 -0.15* -0.01 0.03 -         
11. Pain severity   0.08 0.03 0.13* -0.11* 0.04 -0.13* -0.12* -0.12* -0.10* 0.37** -        
12. Fatigue   0.14* -0.04* 0.02 -0.08 0.04 -0.08 -0.08 -0.32 -0.05 0.27** 0.22** -       
13. Health-related distress   0.01 -0.05 0.05 -0.08 -0.05 0.43** -0.17* -0.05 -0.05 0.36** 0.33** 0.44** -      
14. Work limitation   0.08 -0.01 0.09* -0.17* 0.02 -0.17* -0.13* -0.13* -0.05 0.27** 0.30** 0.36** 0.43** -     
15. Instrumental line manager 
support 
  0.16* 0.10* -0/01 -0.01 0.12* 0.18* 0.11* 0.15* 0.15* 0.01 -0.01 -0.03 -0.10* -0.02 -    
16. Instrumental occupational 
health support 
  -0.10* 0.01 0.07 -0.09 -0.07 0.09* 0.03 0.05 0.07 0.01 -0.02 -0.03 -0.04 -0.03 0.38** -   
17. Instrumental family support   0.07 -0.02 0.02 -0.11* 0.06 0.17* 0.08 0.16* 0.16* 0.06 0.04 -0.01 -0.02 0.03 0.28** 0.17* -  
18. Instrumental GP support   0.02 0.09* 0.05 -0.16** 0.06 0.19* 0.06 0.24** 0.22** 0.05 -0.06 0.01 -0.03 -0.01 0.24** 0.27** 0.39** - 
*p<0.05, **p<0.01.  aGender: 0 = male, 1 = female; cpart-time;  cDichotomised data; dTransformed using log transformation 
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Table IV: Univariate logistic regression model of predictors of prescribed medication 
use at work (n=1474) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
*Controlled for type of organisation 
 
 
 
 
 
Variable *Odds Ratio (95% CI) P value 
 
Age group (years) 
   18-30 
   31-43 
   44-56 
   57-69 
Heart 
Musculoskeletal pain 
Depression & anxiety 
Pain 
   Mild 
   Moderate 
   Severe 
Ease of taking medication at work 
Using medication at home 
Medication beneficial to health 
Instrumental support:  
    Line manager 
    Family 
    General practitioner 
 
 
 
1 
1.24 (0.72-2.16) 
1.77 (1.04-3.02) 
2.04 (1.05-3.94) 
4.19 (1.67-10.49) 
0.38 (0.27 - 0.52) 
0.59 (0.35 - 0.98) 
 
1.73 (1.07 - 2.80) 
1.24 (0.74 - 2.07) 
1 
1.56 (1.50 - 1.64) 
2.06 (1.88 - 2.27) 
1.37 (1.30 - 1.45) 
 
1.28 (1.14 - 1.43) 
1.29 (1.15 - 1.46) 
1.95 (1.43 - 2.65). 
 
 
 
  ns 
  <0.01 
<0.001 
<0.01 
<0.001 
<0.001 
 
<0.001 
  <0.05 
 
<0.001 
<0.001 
<0.001 
 
<0.001 
<0.001 
<0.001 
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Table V: Multivariate logistic regression model of predictors of prescribed medication 
use at work 
 
Variable *Odds Ratio (95% CI) P value 
 
Using medication at home 
Ease of taking medication at work 
 
 
7.26 (4.42-8.83) 
1.45 (1.08-1.64). 
 
<0.001 
<0.001 
*Controlled for age and type of organisation 
 
 
DISCUSSION 
Our study found that medication use at work was predicted by medication use at home 
and the ease of using medication at work. About 85% of respondents with a chronic 
illness reported using medication at work. This high level of usage, combined with the 
increasing prevalence of chronic illness in the workplace as we face an ageing 
workforce (22), highlights the need to better understand medication use at work.  
  
Medication use by illness group showed that employees with heart disease were more 
likely to use medication at work, and employees with arthritis, asthma, depression and 
anxiety, diabetes, migraine and irritable bowel syndrome were more likely to take 
medication at home than at work (tables 2 and 4).  In particular, those with 
musculoskeletal pain and depression and anxiety were less likely to use medication at 
work compared with all other groups (table 4).  Certain factors associated with 
musculoskeletal pain, depression and anxiety but not measured in this study, may help 
to explain the low use of medication by these groups.  For example, the stigma 
associated with depression and anxiety or the possible side effects of psychotropic 
medication use on work performance may deter employees from taking their 
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medication (1-3).  However, it seems more probable that for these illnesses 
medication may be required once or twice a day and therefore outside of working 
hours. 
 
Our findings on predictors of medication use are in line with other studies on 
medication use and adherence (7 8), revealing participants’ age, severity of pain and 
the perception that prescribed medication use is beneficial to health independently 
predicted medication use at work.  In our study, those with mild pain were more likely 
to use medication than those with severe pain, perhaps indicating those using 
medication for pain control are therefore more likely to report lower pain than those 
who are not.  This highlights the importance of reinforcing the benefits of medication 
use for those who are prescribed medication. While this may initially fall within the 
remit of a GP prescribing the medication, primary care providers often have limited 
contact time with the individual; which is often not sufficient for attitude change 
should an individual be sceptical or place a low value on the beneficial properties of 
medication.  Organisations on the other hand could play a vital role in this behaviour 
changing process, through ensuring there is a culture that places a high value on 
health. 
 
In addition, both emotional and practical support from participants’ GP and line 
manager independently predicted medication use at work.  Our results are consistent 
with previous research in that support (practical and emotional) strongly relate to 
medication use and other self-managing behaviours (9-11), and extends those findings 
by indicating the importance of support in the use of medication at work.   
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Our final multiple model suggests that using medication at home and the ease of using 
medication at work were the most parsimonious predictors of using medication at 
work.  Although GP support was the strongest independent predictor of support 
relating to medication use at work, it was not retained in our final model, suggesting 
its’ influence was absorbed by using medication at home.  Although employees were 
more likely to use medication at work if the work environment facilitated the use of 
medication i.e. made it easy for employees to take medication, support from 
occupational health did not predict medication use at work.  However, it is not known 
from the current study, whether occupational health services made the facilitation of 
medication use easier for employees.  For example, implementing a secure box or 
fridge for medications or providing a private room for employees to take medication; 
or by creating a culture of workplace health that encourages employees to manage 
their illness.  Many of these activities may be undertaken by and implemented by both 
management and occupational health services.  
 
A review of each organisations’ policy on medication use at work revealed only one 
organisation had a policy which required employees to disclose medication use for 
health and safety reasons.  However, as the influence of organisational policies was 
controlled for in the analyses, further research is required to understand organisational 
practices for medication use at work, particularly to what extent certain policies and 
practices encourage or deter employees in taking their medication at work, and 
whether lack of medication use have negative physical or psychological health 
outcomes such as pain, fatigue and stress. Further longitudinal intervention-based 
studies are needed to delineate this relationship.   
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While we achieved a below average response rate for mailed surveys of this type 
(12,13), discussions with organisational stakeholders indicate that response rates for 
questionnaires outside of annual employee surveys are in the region of 27-31% due to 
survey fatigue (14). Survey fatigue is an increasing problem faced by researchers 
conducting organisational based research, despite usage of response-inducing 
techniques (14).  As the study relied entirely on self-report data in identifying those 
with chronic illnesses, this may have resulted in under-reporting of chronic illnesses, 
leading to a somewhat lower response rate, or an under-representation of those not 
adhering to medication use.  It is also not possible to know whether employees felt 
uncomfortable in completing a questionnaire about their illness at work, or felt their 
illness posed no problem at work or simply chose not to fill it in due to lack of time.  
Nevertheless, demographic comparisons between responders and non-responders 
indicated no serious problems with response bias. 
 
Further longitudinal research using clinical populations is required to understand what 
factors encourage or deter prescribed medication use at work. Such studies can 
capture information on medication use compliance, changes in medication use, 
employment status and support and the fluctuations of physical, social and 
psychological correlates.  Such information can help occupational health professionals 
design, implement and evaluate appropriate intervention strategies in medication use 
and management to help promote such employees’ well-being and minimise 
subsequent sickness absence.  The focus of this study is worthy of further attention 
not only from a research perspective but also from the point of collaboration between 
healthcare professionals and industries.  
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Implications for clinical practice: The ease of taking medication at work was found to 
be a key predictor of medication use at work, suggesting occupational health may play 
a vital role in findings ways to support employees in their usage of medication. For 
example, by providing help and guidance in storing medication at work and 
encouraging employees to disclose medication use to employers and managers where 
necessary.  Occupational health staff also play an important role in working with 
employees and their line managers and team, to manage possible side effects of 
medication and their possible impact on work performance and safety.  The 
workplace is an ideal environment in which to influence and educate individuals on 
the value of medication and the benefits illness self-management can accrue.  
Occupational health services can help create a workplace culture that places a high 
value on health, educating staff on the value of looking after their health and the 
benefits of following advice given, and work closely with GPs to increase medication 
compliance.  With greater opportunity of contact with individuals, and a number of 
mediums through which to shape behaviour change (e.g. posters, emails, one-to-
ones), occupational health professionals are well positioned to enhance medication 
use at work.  
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KEY POINTS 
 
 Work-related factors associated with prescribed medication use at work 
among employees with chronic illness are of importance given the increasing 
prevalence of chronic illnesses. 
 
 Employees are more likely to use prescribed medication at work if they take 
medication at home and if it is easy for them to take medication at work. 
 
 Occupational health services should adopt an active role in supporting 
employees in managing medication use at work and ensure that they are aware 
of the benefits of taking medication for their illness.   
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